Skip to main content

Kazimi A J's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Dec 5, 2024

Accession no.
0001628280-24-050107
Filed
Dec 5, 2024
Trade date
Nov 1-29, 2024
Filing delay
34 daysLate
Rule 10b5-1 plan
Checked

This filing lists 20 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.75K. It was filed 34 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kazimi A JCIK 0001075050Director, Officer (Chairman and CEO), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 1, 2024Common StockPPurchaseAcquired+76$1.15+$87.45,700,097Direct
Nov 4, 2024Common StockPPurchaseAcquired+49$1.17+$57.335,700,146Direct
Nov 5, 2024Common StockPPurchaseAcquired+76$1.20+$91.25,700,222Direct
Nov 6, 2024Common StockPPurchaseAcquired+76$1.20+$91.25,700,298Direct
Nov 7, 2024Common StockPPurchaseAcquired+76$1.17+$88.925,700,374Direct
Nov 8, 2024Common StockPPurchaseAcquired+76$1.18+$89.685,700,450Direct
Nov 11, 2024Common StockPPurchaseAcquired+76$1.20+$91.25,700,526Direct
Nov 12, 2024Common StockPPurchaseAcquired+76$1.20+$91.25,700,602Direct
Nov 13, 2024Common StockPPurchaseAcquired+76$1.20+$91.25,700,678Direct
Nov 14, 2024Common StockPPurchaseAcquired+76$1.19+$90.445,700,754Direct
Nov 15, 2024Common StockPPurchaseAcquired+76$1.17+$88.925,700,830Direct
Nov 18, 2024Common StockPPurchaseAcquired+76$1.18+$89.685,700,906Direct
Nov 19, 2024Common StockPPurchaseAcquired+76$1.15+$87.45,700,982Direct
Nov 20, 2024Common StockPPurchaseAcquired+85$1.13+$96.055,701,067Direct
Nov 21, 2024Common StockPPurchaseAcquired+85$1.09+$92.655,701,152Direct
Nov 22, 2024Common StockPPurchaseAcquired+75$1.07+$80.255,701,227Direct
Nov 25, 2024Common StockPPurchaseAcquired+75$1.09+$81.755,701,302Direct
Nov 26, 2024Common StockPPurchaseAcquired+75$1.11+$83.255,701,377Direct
Nov 27, 2024Common StockPPurchaseAcquired+75$1.15+$86.255,701,452Direct
Nov 29, 2024Common StockPPurchaseAcquired+75$1.32+$995,701,527Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)